HIV Summer School
EACS HIV Summer School 2017
7-11 September 2017
Montpellier
Applications are now closed.
This 5-day course is designed for clinicians experienced in HIV management who want an update on the current issues in all aspects of HIV medicine and clinical research. It will be delivered by an experienced faculty. The course will consist of updates on the recent advances in current issues in HIV diagnosis, management and prevention together with core knowledge of medical statistics and clinical research methodology.
In addition to the core course, participants will have the opportunity to choose between two parallel modules. Module A will concentrate on research aspects in HIV medicine and module B on the clinical aspects of HIV co-infections, opportunistic infections and co-morbidities.
A maximum of 70 participants can be enrolled. Interested participants must be physicians or clinical scientists working in infectious diseases and/or HIV.
Applicants are selected on their CV and involvement in the HIV field. A moderate fee of 200 euros covers registration and accommodation (due after confirmation). A limited number of scholarships is available to applicants from low-income countries.
The HIV Summer School 2017, Montpellier, France, 07/09/2017-11/09/2017 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 28 European CME Credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
For information about the past courses:
European Clinical Research Course
For previous presentations, check out the Archive!
20th European AIDS Conference
15-18 October 2025 Paris, France
EACS Guidelines updated
The EACS 12.1 and the app are available for free on
Educational Programme
Training and educating the next generation of clinicians and researchers is an EACS core activity.
EACS Resource Library
Access all scientific content of EACS core activities! (members only)
New Interim Guidance
Interim Guidance on the Use of Statin Therapy for the Primary Prevention of Cardiovascular Disease in People with HIV